Zafer E. Ozturk

Sanofi (United States) — United States

Medicine · Health Sciences

11h-index558citations19works2.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Dermatology and Skin Diseases(10), Asthma and respiratory diseases(7), Allergic Rhinitis and Sensitization(6), Inflammatory mediators and NSAID effects(3), Bone health and osteoporosis research(2)

Publications19 total

Conjunctivitis in Adults with Atopic Dermatitis Treated with Dupilumab: An Observational Study of Clinical Characteristics, Symptomatology, and Treatment
Advances in Therapy·2025· 3 citedOpen Access
Attentiveness and mental health in adolescents with moderate-to-severe atopic dermatitis without ADHD
Archives of Dermatological Research·2024· 3 citedOpen Access
Improved sleep parallels improvements in atopic dermatitis signs, symptoms, and quality of life in adult patients treated with dupilumab: 24-week results from the DUPISTAD study
Journal of the American Academy of Dermatology·2024· 1 citedOpen Access
Baseline Demographics, Comorbidities, Treatment Patterns and Burden of Atopic Dermatitis in Adults and Adolescents from the GLOBOSTAD Long-Term Observational Study
Advances in Therapy·2023· 7 citedOpen Access
Dupilumab significantly improves sleep in adults with atopic dermatitis: results from the 12-week placebo-controlled period of the 24-week phase IV randomized double-blinded placebo-controlled DUPISTAD study
British Journal of Dermatology·2023· 21 citedOpen Access
332 Improvement in symptoms of atopic dermatitis (AD) and AD-related quality of life with dupilumab treatment in adults: 24-week results of the DUPISTAD study
British Journal of Dermatology·2023
335 Improvement in sleep quality, anxiety and depression in adults with moderate-to-severe atopic dermatitis with dupilumab treatment
British Journal of Dermatology·2023
Laboratory safety of dupilumab for up to 3 years in adults with moderate-to-severe atopic dermatitis: results from an open-label extension study
Journal of Dermatological Treatment·2021· 20 citedOpen Access
Disease burden and treatment history among adults with atopic dermatitis receiving systemic therapy: baseline characteristics of participants on the EUROSTAD prospective observational study
Journal of Dermatological Treatment·2021· 27 citedOpen Access
Protocol for a prospective, observational, longitudinal study in paediatric patients with moderate-to-severe atopic dermatitis (PEDISTAD): study objectives, design and methodology
BMJ Open·2020· 11 citedOpen Access
Treatment patterns and costs for anti-TNFα biologic therapy in patients with psoriatic arthritis
BMC Musculoskeletal Disorders·2016· 31 citedOpen Access
The Journey of Sporadic Inclusion Body Myositis Patients Before Diagnosis: A Claims-Based Cohort Analyses (P1.128)
Neurology·2016
Effect of zoledronic acid on serum calcium in Paget’s disease patients after educational strategies to improve calcium and vitamin D supplementation
Therapeutic Advances in Endocrinology and Metabolism·2015· 3 citedOpen Access
Interferon therapy in rheumatic diseases: state-of-the-art 2010
Current Opinion in Rheumatology·2010· 37 cited
Prevalence of low hemoglobin levels and associations with other disease parameters in rheumatoid arthritis patients: evidence from the CORRONA registry.
PubMed·2009· 46 cited
Adherence to and Gastrointestinal Tolerability of Monthly Oral or Quarterly Intravenous Ibandronate Therapy in Women with Previous Intolerance to Oral Bisphosphonates: A 12-Month, Open-Label, Prospective Evaluation
Clinical Therapeutics·2008· 39 cited
Efficacy of etoricoxib 60 mg/day and diclofenac 150 mg/day in reduction of pain and disability in patients with chronic low back pain: results of a 4‐week, multinational, randomized, double-blind study
Current Medical Research and Opinion·2005· 62 cited
Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: A randomized controlled trial
Arthritis & Rheumatism·2004· 183 citedOpen Access
A comparison of the therapeutic efficacy and tolerability of etoricoxib and diclofenac in patients with osteoarthritis
Current Medical Research and Opinion·2003· 64 cited

Frequent Co-authors

Marius Ardeleanu(6), Joseph F. Merola(4), Albert S. Chiou(4), Emmanuel During(4), Peter Foley(4), Marjolein de Bruin‐Weller(3), Antonio Costanzo(3), Jiangming Wu(3), Henry G. Bone(2), Silvia Mariel Ferrucci(2), Shyamalie Jayawardena(2), E. Rizova(2), Zhen Chen(2), Brad Shumel(2), Amy S. Paller(2), Jiangming Wu(2), Bernard R. Rubin(1), Robert Burton(1), Sandra Navarra(1), Joseph Antigua(1)